Updated Prostate Cancer Screening Guidelines Announced
Shared decision-making about screening recommended for men aged 55-69 years.
AUA 2013: Prostate Cancer
Prostate Cancer Deaths Occurring at Older Ages
Median survival time from diagnosis improved by a median of 43 months from the pre-PSA to the post-PSA era.
Prostate Cancer Risk Not Elevated with Testosterone Replacement
In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT.
Sildenafil Preserves Erectile Function in Radiotherapy Patients
Data support prophylactic use of a PDE-5 inhibitor in men receiving radiotherapy for prostate cancer.
Intermittent Prostate Cancer Chemo Beneficial
This approach can reduce adverse events without impairing efficacy.
Post-RARP Weight Gain May Worsen Urinary Incontinence
Study finds a significant inverse association between weight changes and incontinence scores in normal-weight patients.
SVI, LNI Have Similar Effect on Prostate Cancer Survival
New findings underscore the importance of achieve maximal tumor control in patients with high-risk disease.
Data Support RP for Localized Advanced Prostate Cancer
Patients with pT4 tumors had five-year cancer-specific and overall survival rates of 91%.
Prostate Cancer Active Surveillance Reasonable, Long-Term Data Show
After more than 10 years of follow-up, 54% of patients progressed, but only one patient died from prostate cancer.
Close Surgical Margins Raise Prostate Cancer Recurrence Risk
Compared with negative margins, they are associated with a 51% increased risk of biochemical relapse
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...